62 related articles for article (PubMed ID: 21474974)
1. Non-neoplastic TdT-positive cells in bone marrow trephines with acute myeloid leukaemia before and after treatment express myeloid molecules.
Jöhrens K; Franke A; Dietel M; Anagnostopoulos I
Pathobiology; 2011; 78(1):35-40. PubMed ID: 21474974
[TBL] [Abstract][Full Text] [Related]
2. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
Kang LC; Dunphy CH
Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
[TBL] [Abstract][Full Text] [Related]
3. Terminal deoxynucleotidyl transferase-positive cells in trephine biopsies following bone marrow or peripheral stem cell transplantation reflect vigorous B-cell generation.
Wolf E; Harms H; Winkler J; Reulbach U; Kirchner T; Niedobitek G; Baumann I
Histopathology; 2005 Apr; 46(4):442-50. PubMed ID: 15810956
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical distinction of haematogones from B lymphoblastic leukaemia/lymphoma or B-cell acute lymphoblastic leukaemia (B-ALL) on bone marrow trephine biopsies: a study on 62 patients.
Al-Shieban S; Byrne E; Trivedi P; Morilla R; Matutes E; Naresh KN
Br J Haematol; 2011 Aug; 154(4):466-70. PubMed ID: 21722099
[TBL] [Abstract][Full Text] [Related]
5. Terminal deoxynucleotidyl transferase positive subpopulations occur in the majority of ANLL: implications for the detection of minimal disease.
Adriaansen HJ; van Dongen JJ; Kappers-Klunne MC; Hählen K; van 't Veer MB; Wijdenes-de Bresser JH; Holdrinet AC; Harthoorn-Lasthuizen EJ; Abels J; Hooijkaas H
Leukemia; 1990 Jun; 4(6):404-10. PubMed ID: 2359340
[TBL] [Abstract][Full Text] [Related]
6. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
[TBL] [Abstract][Full Text] [Related]
7. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
8. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
9. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
[TBL] [Abstract][Full Text] [Related]
10. Expression of CD24 on CD19- CD79a+ early B-cell progenitors in human bone marrow.
Israel E; Kapelushnik J; Yermiahu T; Levi I; Yaniv I; Shpilberg O; Shubinsky G
Cell Immunol; 2005; 236(1-2):171-8. PubMed ID: 16181617
[TBL] [Abstract][Full Text] [Related]
11. [Immunophenotyping in acute leukemia: detection of minimal residual disease].
Pálóczi K; Nahajevszky S; Jakab K; Regéczy N; Gopcsa L; László E; Földi J
Orv Hetil; 2000 Nov; 141(46):2487-92. PubMed ID: 11126681
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor alpha and adiponectin in bone marrow interstitial fluid from patients with acute myeloid leukemia inhibit normal hematopoiesis.
Iversen PO; Wiig H
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6793-9. PubMed ID: 16203766
[TBL] [Abstract][Full Text] [Related]
13. Maturation-associated immunophenotypic abnormalities in bone marrow B-lymphocytes in myelodysplastic syndromes.
Ribeiro E; Matarraz Sudón S; de Santiago M; Lima CS; Metze K; Giralt M; Saad ST; de Matos AO; Lorand-Metze I
Leuk Res; 2006 Jan; 30(1):9-16. PubMed ID: 16005514
[TBL] [Abstract][Full Text] [Related]
14. Terminal deoxynucleotidyl transferase in acute leukemias by direct immunofluorescence.
Nair CN; Gothoskar BP; Gladstone B; Badrinath Y; Chhajlani V; Karnik M; Nerurkar A; Damle SR; Redkar SL; Gopal R
Neoplasma; 1987; 34(3):305-11. PubMed ID: 3302737
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
Molica S; Mannella A; Dattilo A; Levato D; Iuliano F; Peta A; Consarino C; Magro S
Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
[TBL] [Abstract][Full Text] [Related]
16. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of human bone marrow lymphoid progenitor colonies by antibodies to VLA integrins.
Ryan DH; Nuccie BL; Abboud CN
J Immunol; 1992 Dec; 149(11):3759-64. PubMed ID: 1385531
[TBL] [Abstract][Full Text] [Related]
18. Unique pattern of nuclear TdT immunofluorescence distinguishes normal precursor B cells (Hematogones) from lymphoblasts of precursor B-lymphoblastic leukemia.
Hurford MT; Altman AJ; DiGiuseppe JA; Sherburne BJ; Rezuke WN
Am J Clin Pathol; 2008 May; 129(5):700-5. PubMed ID: 18426728
[TBL] [Abstract][Full Text] [Related]
19. Expression of differentiation-associated antigens and adhesion molecules on CD34-positive cells harvested from peripheral blood and bone marrow.
Inaba T; Shimazaki C; Tatsumi T; Yamagata N; Hirata T; Goto H; Fujita N; Nakagawa M
Prog Clin Biol Res; 1994; 389():331-7. PubMed ID: 7535439
[No Abstract] [Full Text] [Related]
20. Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursors.
Farahat N; Lens D; Zomas A; Morilla R; Matutes E; Catovsky D
Br J Haematol; 1995 Nov; 91(3):640-6. PubMed ID: 8555067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]